Key Facts
• On January 6, 2026, Hisamitsu Pharmaceutical announced privatization through a management buyout (MBO).
• President Kazue Nakatomi’s asset management company will conduct a tender offer at 6,082 yen per share.
• Total tender offer amount is about 400 billion yen.
• Tender offer period runs from January 7 to February 19, 2026.
• On January 6, the stock price closed at 5,200 yen, up 15.56% from the previous day.
• The tender offer price is approximately 17% higher than the closing price.
• The company’s board of directors supports the MBO and recommends shareholders participate in the tender offer.
Summary
Hisamitsu Pharmaceutical announced on January 6, 2026, that it will go private through a management buyout led by President Kazue Nakatomi’s asset management company. The tender offer price is set at 6,082 yen per share, totaling about 400 billion yen. The offer period is from January 7 to February 19, 2026. Following preliminary reports, the stock price surged 15.56% to close at 5,200 yen on January 6, with the tender offer price exceeding this by roughly 17%. The board of directors has endorsed the buyout and encourages shareholders to accept the tender offer, marking a significant move toward privatization.
